Has Charles Ross, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,972 in general payments to Charles Ross, MD across 120 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Ross, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Ross, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Ross, MD

Vascular Surgery · Atlanta, GANPI 1326044330

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Boston Scientific at 59.6% of the total. Reporting peaked in 2019 at $5,266 and has fallen 52.1% since, to $2,522 in 2025.

$13,972in general payments, 2019–2025

Across 120 payments — averaging $116.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$8K
Penumbra, Inc.$2K
Angiodynamics, Inc.$967
W. L. Gore & Associates, Inc.$625
EKOS Corporation$401
Johnson & Johnson$336
plus $1K from 16 others

$165,629in research payments, 2019–2025

Across 36 payments — averaging $4600.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$80K
Zimmer Biomet$41K
Vesper Medical$26K
Philips North America LLC$17K
Cook Research Incorporated$2K
EKOS Corporation$250

What the payments were for

Consulting fees$5,43839%
Speaking & faculty fees$2,00014%
Travel & lodging$1,1108%
Food & beverage$5,33338%
Education$921%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	41	$8,322
Penumbra, Inc.	4	$2,295
Angiodynamics, Inc.	8	$967
W. L. Gore & Associates, Inc.	6	$625
EKOS Corporation	11	$401
Johnson & Johnson	17	$336
Cook Medical LLC	2	$188
Medtronic(2 entities)	7	$173
Inari Medical, Inc.	1	$150
Tactile Systems Technology Inc	3	$78
Shockwave Medical, Inc	2	$55
Artivion, Inc.	2	$54
Lemaitre Vascular, Inc.	3	$52
Veryan Medical Incorporated	2	$49
E.r. Squibb & Sons, L.L.C.	2	$38
Silk Road Medical, Inc.	2	$37
Philips North America LLC	1	$36
Baxter Healthcare	2	$36
Abbott	1	$24
Getinge USA Sales, LLC	1	$21
KCI USA, Inc.	1	$18
Atricure, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL VASCULAR INTERVENTION$3,330
GENERAL - THERAPIES$3,000
Indigo System$2,150
GENERAL ANGIOPLASTY$375
AlphaVac$322
EKOSONIC$285
Xcela$249
ANGIOJET$241
GORE VIABAHN VBX Balloon Expandable Endo$172
GENERAL ATHERECTOMY$150
FLOWTRIEVER CATHETER, S$150
CT THROMBECTOMY SYSTEM KIT$150
VenaCure 1470 Pro$149
GORE TAG Thoracic Endoprosthesis$141
GORE VIABAHN Endoprosthesis with Heparin$140
Penumbra System$130
VIABAHN VBX Balloon Expandable Endoprosthesis$117
ELUVIA$116

How this compares

$13,972 in reported general payments places this provider in the 75th percentile of 176 vascular surgery providers in Georgia.

See all vascular surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$274,304

Medicare patients

1,105

Services billed

1,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	76	$57,960
ClopidogrelClopidogrel Bisulfate	24	$175

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Atlanta

Siddharth PatelAtlanta$303K
Walaya Methodius-RayfordAtlanta$79K
Andrew UnzeitigAtlanta$46K
Yazan DuwayriAtlanta$44K
Anumeha WhisenhuntAtlanta$33K
James ChangAtlanta$31K
Chad AlemanAtlanta$21K
Olamide AlabiAtlanta$19K
Jorge CorsoAtlanta$18K
Peter H DoublerAtlanta$15K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →